Race, Difference, and Genes
Race, Difference, and Genes
This chapter situates the CCR5 gene, specifically the Δ32 allele, in the contexts of four distinct yet related enterprises- race and genomics, Big Pharma, personalized medicine, and personal genomics companies. Biocapitalism has fuelled the hopes of personalized medicine (pharmacogenomics), race-based medicine, and the Americans’ fascination with their genealogies. It turns out that various institutions, the National Institutes of Health, the Food and Drug Administration, Big Pharma, personal genomics companies, and patient advocacy groups all support pharmacogenomics but for very different reasons. This chapter discusses those different, and at times mutually exclusive reasons.
Keywords: race and genomics, National Institutes of Health, Food and Drug Administration, HapMap, genetic markers, BigPharma, personal genomics companies, personalized medicine, patient advocacy groups, pharmacogenomics
MIT Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.